HOWL logo

Werewolf Therapeutics, Inc.

HOWL
Healthcare|Biotechnology|US
$1.01
-0.01 (-0.98%)
DCF Value
$1.02
Tangible Book / Share
$0.34
Cash / Share
$0.45
Next Earnings Report
Mar 25, 2027
EPS est. -$0.17 · Revenue est. $13.9M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting
Oct 30, 2026 · GlobeNewsWire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
Sep 24, 2026 · GlobeNewsWire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
Sep 9, 2026 · GlobeNewsWire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ)
Aug 24, 2026 · GlobeNewsWire
HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
Aug 23, 2026 · Business Wire
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
Aug 21, 2026 · GlobeNewsWire

SEC Filings (58)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 26, 2026S-4/ADocumentIndex
Sep 22, 2026S-4DocumentIndex
Sep 21, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 21, 2026425DocumentIndex
Aug 21, 20268-KMaterial eventDocumentIndex
Aug 20, 20268-KMaterial eventDocumentIndex
Jul 31, 202610-QQuarterly reportDocumentIndex
Jul 31, 20268-KMaterial eventDocumentIndex
Jul 2, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 26, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 22, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 15, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 14, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 12, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
May 5, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 27, 202610-KAnnual reportDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Feb 24, 20268-KMaterial eventDocumentIndex
Feb 13, 20268-KMaterial eventDocumentIndex
Feb 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 6, 20268-KMaterial eventDocumentIndex
Jan 16, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 29, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 18, 20258-KMaterial eventDocumentIndex
Dec 3, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 17, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 6, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 4, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 4, 202510-QQuarterly reportDocumentIndex
Nov 4, 20258-KMaterial eventDocumentIndex
Oct 6, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
Aug 14, 20258-KMaterial eventDocumentIndex
Jun 13, 20258-KMaterial eventDocumentIndex
May 15, 2025EFFECTDocumentIndex
May 15, 20258-KMaterial eventDocumentIndex
May 14, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex